Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 74


Influence of pH on viscoelastic properties of heat-induced gels obtained with a β-Lactoglobulin fraction isolated from bovine milk whey hydrolysates.

Estévez N, Fuciños P, Bargiela V, Picó G, Valetti NW, Tovar CA, Rúa ML.

Food Chem. 2017 Mar 15;219:169-178. doi: 10.1016/j.foodchem.2016.09.137.


Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.

Brown GK, Tovar C, Cooray AA, Kreiss A, Darby J, Murphy JM, Corcoran LM, Bettiol SS, Lyons AB, Woods GM.

Immunol Cell Biol. 2016 Aug;94(7):673-9. doi: 10.1038/icb.2016.38.


Structural and thermo-rheological analysis of solutions and gels of a β-lactoglobulin fraction isolated from bovine whey.

Estévez N, Fuciños P, Bargiela V, Pastrana L, Tovar CA, Luisa Rúa M.

Food Chem. 2016 May 1;198:45-53. doi: 10.1016/j.foodchem.2015.11.090.


A second transmissible cancer in Tasmanian devils.

Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, Fox S, Darby J, Hayes D, Knowles GW, Kreiss A, Siddle HV, Swift K, Lyons AB, Murchison EP, Woods GM.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):374-9. doi: 10.1073/pnas.1519691113.


Topological data analysis for discovery in preclinical spinal cord injury and traumatic brain injury.

Nielson JL, Paquette J, Liu AW, Guandique CF, Tovar CA, Inoue T, Irvine KA, Gensel JC, Kloke J, Petrossian TC, Lum PY, Carlsson GE, Manley GT, Young W, Beattie MS, Bresnahan JC, Ferguson AR.

Nat Commun. 2015 Oct 14;6:8581. doi: 10.1038/ncomms9581.


Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil.

Patchett AL, Latham R, Brettingham-Moore KH, Tovar C, Lyons AB, Woods GM.

Dev Comp Immunol. 2015 Nov;53(1):123-33. doi: 10.1016/j.dci.2015.07.003.


Stress exacerbates neuron loss and microglia proliferation in a rat model of excitotoxic lower motor neuron injury.

Puga DA, Tovar CA, Guan Z, Gensel JC, Lyman MS, McTigue DM, Popovich PG.

Brain Behav Immun. 2015 Oct;49:246-54. doi: 10.1016/j.bbi.2015.06.006.


Immunology of a Transmissible Cancer Spreading among Tasmanian Devils.

Woods GM, Howson LJ, Brown GK, Tovar C, Kreiss A, Corcoran LM, Lyons AB.

J Immunol. 2015 Jul 1;195(1):23-9. doi: 10.4049/jimmunol.1500131. Review.


Establishment and multi drug resistance evolution of ST235 Pseudomonas aeruginosa strains in the intensive care unit of a Colombian hospital.

Martinez E, Pérez JE, Buelvas F, Tovar C, Vanegas N, Stokes HW.

Res Microbiol. 2014 Dec;165(10):852-6. doi: 10.1016/j.resmic.2014.10.011.


Independent evaluation of the anatomical and behavioral effects of Taxol in rat models of spinal cord injury.

Popovich PG, Tovar CA, Lemeshow S, Yin Q, Jakeman LB.

Exp Neurol. 2014 Nov;261:97-108. doi: 10.1016/j.expneurol.2014.06.020.


Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy.

Zhang Z, Ding Q, Liu JJ, Zhang J, Jiang N, Chu XJ, Bartkovitz D, Luk KC, Janson C, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev LT, Graves B.

Bioorg Med Chem. 2014 Aug 1;22(15):4001-9. doi: 10.1016/j.bmc.2014.05.072.


Dose reduction of efavirenz: an observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics.

Martín AS, Gómez AI, García-Berrocal B, Figueroa SC, Sánchez MC, Calvo Hernández MV, Gonzalez-Buitrago JM, Valverde Merino MP, Tovar CB, Martín AF, Isidoro-García M.

Pharmacogenomics. 2014 May;15(7):997-1006. doi: 10.2217/pgs.14.48.


Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development.

Zhang Z, Chu XJ, Liu JJ, Ding Q, Zhang J, Bartkovitz D, Jiang N, Karnachi P, So SS, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev L, Graves B.

ACS Med Chem Lett. 2013 Dec 29;5(2):124-7. doi: 10.1021/ml400359z.


Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development.

Vu B, Wovkulich P, Pizzolato G, Lovey A, Ding Q, Jiang N, Liu JJ, Zhao C, Glenn K, Wen Y, Tovar C, Packman K, Vassilev L, Graves B.

ACS Med Chem Lett. 2013 Apr 2;4(5):466-9. doi: 10.1021/ml4000657.


Preclinical optimization of MDM2 antagonist scheduling for cancer treatment by using a model-based approach.

Higgins B, Glenn K, Walz A, Tovar C, Filipovic Z, Hussain S, Lee E, Kolinsky K, Tannu S, Adames V, Garrido R, Linn M, Meille C, Heimbrook D, Vassilev L, Packman K.

Clin Cancer Res. 2014 Jul 15;20(14):3742-52. doi: 10.1158/1078-0432.CCR-14-0460.


Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors.

Howson LJ, Morris KM, Kobayashi T, Tovar C, Kreiss A, Papenfuss AT, Corcoran L, Belov K, Woods GM.

Anat Rec (Hoboken). 2014 May;297(5):925-38. doi: 10.1002/ar.22904.


Low-dose amphotericin B and murine dialyzable spleen extracts protect against systemic candida infection in mice.

Robledo-Ávila F, Pérez-Tapia M, Limón-Flores A, Pavon L, Hernández-Pando R, Wong-Baeza I, González-González G, Tovar C, Estrada-Parra S, Estrada-García I.

Clin Dev Immunol. 2013;2013:194064. doi: 10.1155/2013/194064.


Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.

Chang YS, Graves B, Guerlavais V, Tovar C, Packman K, To KH, Olson KA, Kesavan K, Gangurde P, Mukherjee A, Baker T, Darlak K, Elkin C, Filipovic Z, Qureshi FZ, Cai H, Berry P, Feyfant E, Shi XE, Horstick J, Annis DA, Manning AM, Fotouhi N, Nash H, Vassilev LT, Sawyer TK.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3445-54. doi: 10.1073/pnas.1303002110.


Determining the response of African biota to climate change: using the past to model the future.

Willis KJ, Bennett KD, Burrough SL, Macias-Fauria M, Tovar C.

Philos Trans R Soc Lond B Biol Sci. 2013;368(1625):20120491. doi: 10.1098/rstb.2012.0491. Review.

Items per page

Supplemental Content

Support Center